• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙酮辅助下将美洛昔康与氨基酸共处理以提高溶解速率。

Acetone-assisted co-processing of meloxicam with amino acids for enhanced dissolution rate.

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information, Cairo, Egypt.

Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

出版信息

Pharm Dev Technol. 2020 Sep;25(7):882-891. doi: 10.1080/10837450.2020.1755982. Epub 2020 Apr 22.

DOI:10.1080/10837450.2020.1755982
PMID:32281899
Abstract

Meloxicam is a widely used non-steroidal anti-inflammatory agent. However, its erratic and poor dissolution delays its onset of action. Dissolution enhancement of such medicine is essential to obtain rapid pain relief. Amino acids showed high potential to enhance the dissolution rate of drugs after co-processing. Accordingly, the objective of this work was to investigate the effect of co-processing of meloxicam with arginine, cysteine, and glycine on its crystalline structure and dissolution rate. Meloxicam was mixed with increasing molar ratios of amino acids before acetone-assisted kneading. The resulting products were examined using Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction in addition to monitoring the dissolution behavior. Combined instrumental analysis indicated salt formation with a possibility of further crystalline changes at high concentration of amino acids. Salt formation and crystalline structure modification were associated with a significant increase in the dissolution rate of meloxicam. The study introduced amino acids as potential excipients for enhanced dissolution of meloxicam after wet co-processing.

摘要

美洛昔康是一种广泛使用的非甾体抗炎药。然而,其不规则和较差的溶解度会延迟其作用的开始。增强这种药物的溶解度对于获得快速的疼痛缓解至关重要。氨基酸在药物共加工后显示出提高药物溶解速度的巨大潜力。因此,本工作的目的是研究美洛昔康与精氨酸、半胱氨酸和甘氨酸共加工对其晶体结构和溶解速率的影响。在丙酮辅助捏合之前,将美洛昔康与氨基酸以递增的摩尔比混合。使用傅里叶变换红外光谱、差示扫描量热法和 X 射线衍射对所得产物进行了检查,同时监测了溶解行为。联合仪器分析表明,在氨基酸浓度较高时可能形成盐,同时存在进一步的晶体变化的可能性。盐形成和晶体结构的改变与美洛昔康溶解速率的显著提高有关。该研究介绍了氨基酸作为潜在的辅料,通过湿共加工可增强美洛昔康的溶解度。

相似文献

1
Acetone-assisted co-processing of meloxicam with amino acids for enhanced dissolution rate.丙酮辅助下将美洛昔康与氨基酸共处理以提高溶解速率。
Pharm Dev Technol. 2020 Sep;25(7):882-891. doi: 10.1080/10837450.2020.1755982. Epub 2020 Apr 22.
2
Ethanol-assisted kneading of apigenin with arginine for enhanced dissolution rate of apigenin: development of rapidly disintegrating tablets.乙醇辅助槲皮素与精氨酸揉捏提高槲皮素溶出速率:速崩片的研制。
Pharm Dev Technol. 2021 Jul;26(6):693-700. doi: 10.1080/10837450.2021.1922441. Epub 2021 May 6.
3
Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.共结晶提高比卡鲁胺溶出速率:速崩片的制备与评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1215-1223. doi: 10.1080/03639045.2019.1571504. Epub 2019 May 27.
4
In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.萘普生-精氨酸晶型盐和共无定形盐的体外和体内比较。
Eur J Pharm Biopharm. 2018 Nov;132:192-199. doi: 10.1016/j.ejpb.2018.09.024. Epub 2018 Sep 25.
5
Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.美洛昔康-辣木胶-PVP 三元固体分散体的固态特征和溶解性能。
AAPS PharmSciTech. 2013 Jun;14(2):569-77. doi: 10.1208/s12249-013-9941-5. Epub 2013 Mar 13.
6
Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.氨基酸作为低水溶解性药物的共无定形稳定剂——第 1 部分:制备、稳定性和溶出度的提高。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):873-81. doi: 10.1016/j.ejpb.2013.03.014. Epub 2013 Mar 26.
7
Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets.三氯蔗糖作为氢氯噻嗪的共晶共形成物:口腔崩解片的研发
Drug Dev Ind Pharm. 2016 Aug;42(8):1225-33. doi: 10.3109/03639045.2015.1118495. Epub 2015 Dec 7.
8
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.喷雾干燥共无定形药物 - 氨基酸盐的制备与表征
J Pharm Pharmacol. 2016 May;68(5):615-24. doi: 10.1111/jphp.12458. Epub 2015 Aug 5.
9
Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188.美洛昔康与泊洛沙姆 188 制备二元固体分散体的揉合技术。
AAPS PharmSciTech. 2009;10(4):1206-15. doi: 10.1208/s12249-009-9316-0. Epub 2009 Oct 28.
10
Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000.美洛昔康与聚乙二醇6000固体分散体的制备、表征及体外溶出度研究
Yakugaku Zasshi. 2006 Aug;126(8):657-64. doi: 10.1248/yakushi.126.657.

引用本文的文献

1
Cutting-Edge Approaches in the Co-Amorphization Process.共非晶化过程中的前沿方法。
Pharmaceutics. 2025 Jun 29;17(7):850. doi: 10.3390/pharmaceutics17070850.
2
Pharmaceutical Salts of Piroxicam and Meloxicam with Organic Counterions.吡罗昔康和美洛昔康与有机抗衡离子形成的药用盐。
Cryst Growth Des. 2022 Oct 21;22(11):6504-6520. doi: 10.1021/acs.cgd.2c00722. eCollection 2022 Nov 2.
3
A Review of Coformer Utilization in Multicomponent Crystal Formation.共晶物在多组分晶体形成中的应用综述。
Molecules. 2022 Dec 8;27(24):8693. doi: 10.3390/molecules27248693.
4
Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review.氨基酸作为共晶形成的潜在共形成物:综述。
Molecules. 2021 May 28;26(11):3279. doi: 10.3390/molecules26113279.